SS Innovations International, Inc. Cash Flow Statement
SSII / Health Care|10 years of annual SEC 10-K data (FY2016-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 10 fiscal years. All figures from audited SEC 10-K filings.
SS Innovations International, Inc. used $19M in operating cash flow and negative free cash flow of $22M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.26 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$12.1M | -$20.9M | -$20.9M | -$5.6M | -$1.5M | -$1.1M | -$3.4M | -$960.3K | -$1.0M | -$485.0K |
| Depreciation & Amortization | $1.1M | $152.7K | $152.7K | $128.9K | $18.8K | $37.4K | $37.7K | $19.5K | $789 | - |
| Operating Cash Flow | -$18.5M | -$15.4M | -$15.4M | -$5.6M | -$363.0K | -$90.5K | -$424.1K | -$443.3K | -$446.9K | -$211.9K |
| Capital Expenditures | $3.7M | $453.3K | $453.3K | $220.3K | - | - | - | - | - | - |
| Free Cash Flow | -$22.2M | -$15.8M | -$15.8M | -$5.8M | - | - | - | - | - | - |
| Share Buybacks | - | - | - | - | $26.0K | - | - | - | - | - |
| FCF Margin | -52.3% | -269.2% | - | - | - | - | - | - | - | - |